Name | ikarugamycin |
---|---|
Synonyms |
14,17-Metheno-17H-as-indaceno[3,2-k][1,6]diazacycloheptadecine-9,16,18(1H)-trione, 3-ethyl-2,3,3a,5a,5b,6,10,11,12,13,14,15,20a,21,21a,21b-hexadecahydro-22-hydroxy-2-methyl-, (2R,3R,3aS,5aR,5bS,7Z,14S,19E,20aS,21aR,21bR)-
(3E,5S,7R,8R,10R,11R,12S,15R,16S,18Z,25S)-11-Ethyl-28-hydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0.0.0]octacosa-1(28),3,13,18-tetraene-2,20,27-trione Ikarugamycin tu-6239 c3 |
Description | Ikarugamycin is an antibiotic and a inhibitor of clathrin-mediated endocytosis (CME)[1]. |
---|---|
Related Catalog | |
Target |
Clathrin-mediated endocytosis[1] |
In Vitro | Ikarugamycin has an IC50 of 2.7 μM in H1299 cells[1]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 741.9±60.0 °C at 760 mmHg |
Molecular Formula | C29H38N2O4 |
Molecular Weight | 478.62 |
Flash Point | 402.5±32.9 °C |
Exact Mass | 478.283173 |
PSA | 95.50000 |
LogP | 5.05 |
Vapour Pressure | 0.0±5.6 mmHg at 25°C |
Index of Refraction | 1.604 |
Storage condition | -20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301 |
Precautionary Statements | P301 + P310 |
Hazard Codes | T |
RIDADR | UN 2811 6.1 / PGIII |
Precursor 2 | |
---|---|
DownStream 0 |